Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|
| Revenue | 355M | 322M | 326M | 331M | 300M | 300M |
| Cost of revenue | 98M | 94M | 93M | 107M | 103M | 96M |
| Gross profit | 256M | 228M | 233M | 224M | 197M | 204M |
| Research and development | 68M | 66M | 65M | 61M | 60M | 59M |
| Selling, general and administrative | 31M | 31M | 30M | 26M | 32M | 32M |
| Operating expenses | 153M | 149M | 143M | 141M | 177M | 145M |
| Operating income | 103M | 79M | 90M | 83M | 20M | 59M |
| Pre-tax income | 92M | 68M | 78M | 71M | 6M | 47M |
| Income tax | 23M | 16M | 18M | 17M | 515,000 | 11M |
| Net income | 69M | 52M | 60M | 54M | 6M | 36M |
| Earnings per share | 0.82 | 0.60 | 0.69 | 0.62 | 0.07 | 0.41 |
| Earnings per share, diluted | 0.82 | 0.59 | 0.68 | 0.61 | 0.06 | 0.40 |
| Weighted average shares | 84M | 86M | 87M | 87M | 87M | 87M |
| Weighted average shares, diluted | 85M | 87M | 88M | 88M | 89M | 89M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 265M | 319M | 309M | 304M | 288M | 296M | 322M | 327M |
| Receivables | 122M | 124M | 111M |
| Metric | 30 Apr 2026 | 30 Apr 2025 |
|---|---|---|
| Operating cash flow | 98M | 65M |
| Depreciation and amortisation | 38M | 39M |
| Share-based compensation | 19M | 14M |
| Capital expenditure | 362,000 | 86,000 |
| Investing cash flow | −14M | −16M |
| Share buybacks | 123M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 111M |
| 116M |
| 118M |
| 107M |
| 108M |
| Current assets | 467M | 512M | 499M | 493M | 473M | 478M | 495M | 496M |
| Property, plant and equipment | 4M | 3M | 3M | 3M | 3M | 3M | 4M | 5M |
| Goodwill | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
| Total assets | 3.31B | 3.38B | 3.40B | 3.42B | 3.42B | 3.45B | 3.49B | 3.51B |
| Current liabilities | 136M | 157M | 121M | 117M | 116M | 156M | 155M | 121M |
| Long-term debt | 943M | 957M | 982M | 1.01B | 1.06B | 1.06B | 1.08B | 1.10B |
| Total liabilities | 1.26B | 1.27B | 1.26B | 1.27B | 1.29B | 1.33B | 1.36B | 1.36B |
| Equity | 2.05B | 2.11B | 2.13B | 2.15B | 2.12B | 2.11B | 2.12B | 2.16B |
| Shares outstanding | 84M | 85M | 86M | 86M | 87M | 87M | 87M | 87M |
| Shares issued | 84M | 85M | 86M | 86M | 87M | 87M | 87M | 87M |
| 59M |
| Financing cash flow | −137M | −57M |